Panacos Pharmaceuticals (PANC) Reports Q3 Loss of $0.15, Beats by 5c
More News related to PANC
- Panacos Pharmaceuticals (PANC) Hires Oppenheimer & Co. to Review Strategic Alternatives; Reduces Workforce
- Panacos Pharmaceuticals (PANC) Reports Q3 Loss of $0.15, Beats by 5c
- Panacos Pharmaceuticals, Inc. (PANC) Reports Q3 In-Line
- Pre-Open Movers 6/18: Lindsay Corp (LNN) Lower After Results, Fifth Third (FITB) Sinks on Capital Raise/Div Cut/Revised Capital Ratio
- Panacos Pharmaceuticals (PANC) Reports Q1 Loss of $0.16, Tops Street By 3c
Panacos Pharmaceuticals, Inc. (Nasdaq: PANC) reports Q3 loss of $0.15, 5 cents better than the analyst estimate of ($0.20).
Related Categories
EarningsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
